… ability” to ward off HIV infection in two major international … jab will compete with GSK-arm ViiV Healthcare's Apretude prevention … for people with multidrug-resistant HIV under the brand Sunlenca … #39;s Emergency Plan for AIDS Relief (PEPFAR), and others, …

… Navigator Network newly funded by ViiV will offer quarterly in- … to Acquired Immuno-Deficiency Syndrome (AIDS).   HIV disproportionately affects racial and ethnic … Rights Campaign Foundation for LGBTQ+ healthcare access. Through strategic collaborations and …

… taken daily and cabotegravir (Apretude; ViiV Healthcare) that needs to be taken … , FIDSA, associate professor of medicine (AIDS) and of pharmacology at Yale … -announcements/fda-approves-new-hiv-drug-adults-limited-treatment-options …

… for HIV prevention for certain populations in 2019. ViiV Healthcare’s … at the 2024 International AIDS Conference and published in … President’s Emergency Plan for AIDS Relief, which has been … at ending AIDS.” Click here for more news about HIV prevention.

… two-month injection made by ViiV and sold under the … PrEP, individual awareness about HIV risk, and complicated procurement … shown 99% efficacy in preventing HIV infection, but its manufacturer, … opportunity to end AIDS," a condition caused by HIV, but …

… hit the market for HIV prevention. The other, ViiV Healthcare’s cabotegravir, was … a potentially transformative medication for HIV prevention, capable of hastening the … strong headwinds, preventing transmission and HIV acquisition have made tremendous progress …

… President’s Emergency Plan for AIDS Relief (PEPFAR), which … identified the virus that causes AIDS. A vaccine, she declared … a capsid-targeting molecule Pfizer abandoned when it shuttered … injectable drug to prevent HIV, after ViiV Healthcare’s once-every-two …

… ’s landmark long-acting HIV treatment lenacapavir Wednesday afternoon. … patients with treatment-resistant HIV and had received prior … factors. Yeztugo joins GSK and ViiV’s Aprectude as the … drug achieved 100% prevention of HIV transmission, according to Gilead …

… company’s daily pill for HIV prevention. Shares of Gilead … the decades-long fight against HIV,” Gilead Chief Executive Officer … prevention shot from ViiV Healthcare, majority-owned by GSK Plc, that’s … because of the stigma surrounding HIV, or because they worry …

… highly-effective drug to prevent HIV infection. The twice-yearly … at risk of contracting HIV. They include daily pills … every-other-month shot from ViiV Healthcare called Apretude. Infections have … programs, including grants for HIV research. The 2026 budget …